​​Oncology: Breast Cancer

Medicine®, a Wolters Kluwer Health publication and one of the most respected and frequently cited journals in general medicine, is pleased to announce the launch of Medicine®: Breast Cancer, an online channel of content specifically dedicated to the publication and distribution of Breast Cancer-related research within Medicine®.

Medicine®: Breast Cancer will consider submissions in the following subject areas:

  • Diagnosis and Evaluation of Breast Disease
  • Treatment and Management of breast Cancer
  • Pathology and Biological Markers of Invasive Breast Cancer
  • Breast Imaging and Biopsy Techniques
  • Preoperative Systematic Therapy
  • Evaluation After Primary Therapy and Recurring Breast Cancer
  • New Breast Cancer Therapeutic Approaches
  • ​Site-Specific Therapy of Metastatic Breast Cancer

Click here to view the Medicine®: Breast Cancer Editorial Board

Submissions to Medicine®: Breast Cancer will be published and indexed under the Medicine® ISSN.

Submit Your Manuscript

(note: Select section/category "5750 Breast Cancer Channel" during submission process)



333 results

Current Filters:

Association of neutrophil-to-lymphocyte ratio with clinical, pathological, radiological, laboratory features and disease outcomes of invasive breast cancer patients: A retrospective observational cohort study

Jadoon, Sarosh Khan; Soomro, Rufina; Ahsan, Muhammad Nadeem; More

Medicine. 102(20):e33811, May 19, 2023.

Successful use of minimal invasive debridement plus negative pressure wound therapy under skin flap and axillary region for refractory postmastectomy seroma: A STROBE-compliant retrospective study

Esen, Ebru; Saydam, Mehmet; Guler, Sumeyra; More

Medicine. 101(43):e31634, October 28, 2022.

Clinical study on Yanghe decoction in improving neo-adjuvant chemotherapy efficacy and immune function of breast cancer patients

Zhang, Xinyue; Hu, Minhao; Li, Siyu; More

Medicine. 101(10):e29031, March 11, 2022.

Potential association of prolonged patient interval and advanced anatomic stage in breast cancer patients in the area affected by the 2011 triple disaster in Fukushima, Japan: Retrospective observational study

Ozaki, Akihiko; Toyoaki, Sawano; Tsukada, Manabu; More

Medicine. 100(32):e26830, August 13, 2021.

Positive estrogen receptor status is a poor prognostic factor in node-negative breast cancer: An observational study in Asian patients

Jung, Eun Jung; Kim, Ju-Yeon; Kim, Jae-Myung; More

Medicine. 100(11):e25000, March 19, 2021.

Management of the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: A single-center study

Aksoy, Suleyman Ozkan; Sevinc, Ali İbrahim; Ünal, Mücahit; More

Medicine. 99(49):e23538, December 4, 2020.

  • Open

A phase I study of pharmacokinetics of trastuzumab emtansine in Chinese patients with locally advanced inoperable or metastatic human epidermal growth factor receptor 2-positive breast cancer who have received prior trastuzumab-based therapy

Ji, Dongmei; Shen, Weina; Zhang, Jian; More

Medicine. 99(44):e22886, October 30, 2020.

Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatment

Watanuki, Rurina; Shimomura, Akihiko; Yazaki, Shu; More

Medicine. 99(38):e22331, September 18, 2020.